CoChat

Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences

Riestenberg, Carrie, Jagasia, Anika, Markovic, Daniela, Buyalos, Richard P, Azziz, Ricardo · 2022 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Context: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women, affecting approximately 5% to 20% of women of reproductive age. The economic burden of PCOS was previously estimated at approximately $3.7 billion annually in 2020 USD when considering only the costs of the initial diagnosis and of reproductive endocrine morbidities, without considering the costs of pregnancy-related and long-term morbidities. Objective: This study aimed to estimate the excess prevalence and economic burden of pregnancy-related and long-term health morbidities attributable to PCOS. Methods: PubMed, EmBase, and Cochrane Library were searched, and studies were selected in which the diagnosis of PCOS was consistent with the Rotterdam, National Institutes of Health, or Androgen Excess and PCOS Society criteria, or that used electronic medical record diagnosis codes, or diagnosis based on histopathologic sampling. Studies that included an outcome of interest and a control group of non-PCOS patients who were matched or controlled for body mass index were included. Two investigators working independently extracted data on study characteristics and outcomes. Data were pooled using random effects meta-analysis. The I2 statistic was used to assess inter-study heterogeneity. The quality of selected studies was assessed using the Newcastle-Ottawa Scale. Results: The additional total healthcare-related economic burden of PCOS due to pregnancy-related and long-term morbidities in the United States is estimated to be $4.3 billion annually in 2020 USD. Conclusion: Together with our prior analysis, the economic burden of PCOS is estimated at $8 billion annually in 2020 USD.

Overview

Integrity signals

Registry

Crossref · 10.1210/clinem/dgab613

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 5

  1. Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome; towards a rational approach, 337
  2. Rohde, 2012, Health Care Expenditures for Uncomplicated Pregnancies, 2009
  3. Martin, 2019, Births: final data for 2018, Natl Vital Stat Rep., 68, 1
  4. American College of Obstetricians, Task Force on Hypertension in Pregnancy, 2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Obstetrics and Gynecology, 1122
  5. Pourat, 2013, Costs of Gestational Hypertensive Disorders in California: Hypertension, Preeclampsia, and Eclampsia

Cited by

See all 210

Metadata

Authors
Riestenberg, C., Jagasia, A., Markovic, D., Buyalos, R. P., & Azziz, R.
Affiliations
  • University of California, Los Angeles (US)
  • University of Pennsylvania (US)
Corresponding author
Azziz, Ricardo
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2021-09-21
Volume
107
Issue
2
Pages
575-585
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3199422888
Cited by
210
References
36
Citations by year
2026: 58 · 2025: 56 · 2024: 35 · 2023: 37 · 2022: 21 · 2021: 3
FWCI
3.99
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Foundation for Research and Education Excellence
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, economic burden, health care costs, pregnancy complications, long-term health effects
MeSH terms
Health Expenditures, Female, Humans, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, United States, Comorbidity, Prevalence, Case-Control Studies, Health Care Costs, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.